Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Browse the world's most comprehensive archive of hedge fund manager letters. Access primary source research from leading institutional managers, sorted by reporting period.
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
Full Quick Take
Jacob Funds capitalized on Q4 market volatility and tech cooling by selectively adding high-conviction growth names like Snowflake in cloud/AI infrastructure, alongside cutting-edge biotech innovators Cabaletta Bio and Prime Medicine.
